Country sequencing, vendor geography, and QP release chains are strategic decisions made, well or poorly, at the US IND stage, long before a company believes it is ready to think globally.
White Paper
Designing a Global IND Strategy Before You Think You Need One
Related Resources
All Resources
white-paper
A Novel Power BI Tool to Monitor Change Controls and Key Performance Indicators
Read More
white-paper
Optimizing Clinical Supply Chain Management
Read More
post
The Importance of Stability Studies in CMC Compliance
Read More
post
Understanding the FDA’s Evolving Expectations for Biopharma Compliance
Read More
Let's move from science to success.
Let’s Talk